Owens & Minor Total Assets 2006-2018 | OMI

Owens & Minor total assets from 2006 to 2018. Total assets can be defined as the sum of all assets on a company's balance sheet.
Owens & Minor Annual Total Assets
(Millions of US $)
2018 $3,774
2017 $3,376
2016 $2,718
2015 $2,774
2014 $2,735
2013 $2,324
2012 $2,214
2011 $1,947
2010 $1,822
2009 $1,747
2008 $1,776
2007 $1,528
2006 $1,686
2005 $1,240
Owens & Minor Quarterly Total Assets
(Millions of US $)
Q4 2018 $3,774
Q3 2018 $4,032
Q2 2018 $4,043
Q1 2018 $3,392
Q4 2017 $3,376
Q3 2017 $3,334
Q2 2017 $2,795
Q1 2017 $2,701
Q4 2016 $2,718
Q3 2016 $2,795
Q2 2016 $2,756
Q1 2016 $2,797
Q4 2015 $2,774
Q3 2015 $2,752
Q2 2015 $2,795
Q1 2015 $2,700
Q4 2014 $2,735
Q3 2014 $2,944
Q2 2014 $2,364
Q1 2014 $2,369
Q4 2013 $2,324
Q3 2013 $2,348
Q2 2013 $2,379
Q1 2013 $2,321
Q4 2012 $2,214
Q3 2012 $2,222
Q2 2012 $1,955
Q1 2012 $1,925
Q4 2011 $1,947
Q3 2011 $1,950
Q2 2011 $1,906
Q1 2011 $1,911
Q4 2010 $1,822
Q3 2010 $1,841
Q2 2010 $1,805
Q1 2010 $1,749
Q4 2009 $1,747
Q3 2009 $1,697
Q2 2009 $1,689
Q1 2009 $1,687
Q4 2008 $1,776
Q3 2008 $1,572
Q2 2008 $1,586
Q1 2008 $1,537
Q4 2007 $1,528
Q3 2007 $1,568
Q2 2007 $1,640
Q1 2007 $1,682
Q4 2006 $1,686
Q3 2006 $1,455
Q2 2006 $1,306
Q1 2006 $1,275
Q4 2005 $1,240
Q3 2005 $1,231
Q2 2005 $1,186
Q1 2005 $1,171
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.283B $9.839B
Owens & Minor, Inc. is a global healthcare solutions company dedicated to Connecting the World of Medical Products to the Point of CareSM by providing vital supply chain services to healthcare providers and manufacturers of healthcare products. Owens & Minor provides logistics services across the spectrum of medical products from disposable medical supplies to devices and implants. With logistics platforms strategically located in the United States and Europe, Owens & Minor serves markets where three quarters of global healthcare spending occurs. Owens & Minor's customers span the healthcare market from independent hospitals to large integrated healthcare networks, as well as group purchasing organizations, healthcare products manufacturers, the federal government, and healthcare patients at home through the Byram Healthcare subsidiary.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $140.447B 27.76
Medtronic (MDT) Ireland $124.271B 18.17
Stryker (SYK) United States $73.087B 26.83
Boston Scientific (BSX) United States $52.902B 25.79
Baxter (BAX) United States $39.768B 25.44
Zimmer Biomet Holdings (ZBH) United States $25.701B 16.45
Smith & Nephew SNATS (SNN) United Kingdom $17.481B 0.00
Canopy Growth (CGC) Canada $15.431B 0.00
ResMed (RMD) United States $14.029B 26.60
Aurora Cannabis (ACB) Canada $10.082B 71.14
Bio-Rad Laboratories (BIO) United States $9.411B 53.70
Hill-Rom Holdings (HRC) United States $6.960B 21.53
Perrigo (PRGO) Ireland $6.690B 10.85
Insulet (PODD) United States $5.859B 1976.60
GW Pharmaceuticals (GWPH) United Kingdom $5.071B 0.00
ICU Medical (ICUI) United States $4.915B 30.60
Haemonetics (HAE) United States $4.429B 39.29
Hutchison China MediTech (HCM) China $3.856B 0.00
Agios Pharmaceuticals (AGIO) United States $3.806B 0.00
Neogen (NEOG) United States $3.332B 51.18
NuVasive (NUVA) United States $2.882B 25.14
Quidel (QDEL) United States $2.658B 23.98
Aphria (APHA) $2.606B 115.67
National Vision Holdings (EYE) United States $2.333B 45.89
HEXO (HEXO) $1.460B 0.00
Cardiovascular Systems (CSII) United States $1.372B 985.25
VAREX IMAGING (VREX) United States $1.306B 25.56
Phibro Animal Health (PAHC) United States $1.294B 18.60
AtriCure (ATRC) United States $1.108B 0.00
Lantheus Holdings (LNTH) United States $0.947B 25.58
MacroGenics (MGNX) United States $0.921B 0.00
Cerus (CERS) United States $0.868B 0.00
Omeros (OMER) United States $0.861B 0.00
PetIQ (PETQ) United States $0.815B 23.33
NanoString Technologies (NSTG) United States $0.755B 0.00
Evolus (EOLS) United States $0.725B 0.00
OraSure Technologies (OSUR) United States $0.713B 31.24
Meridian Bioscience (VIVO) United States $0.705B 21.00
Eagle Pharmaceuticals (EGRX) United States $0.680B 23.15
TG Therapeutics (TGTX) United States $0.653B 0.00
Surmodics (SRDX) United States $0.616B 89.55
LeMaitre Vascular (LMAT) United States $0.610B 29.03
Quanterix (QTRX) United States $0.550B 0.00
BioLife Solutions (BLFS) United States $0.376B 155.15
Insys Therapeutics (INSY) United States $0.358B 0.00
Rockwell Medical (RMTI) United States $0.357B 0.00
Vapotherm (VAPO) United States $0.335B 0.00
Utah Medical Products (UTMD) United States $0.313B 20.35
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.270B 0.00
Bovie Medical (APYX) United States $0.266B 0.00
Cytosorbents (CTSO) United States $0.252B 0.00
Fonar (FONR) United States $0.143B 7.64
Surface Oncology (SURF) United States $0.142B 0.00
Zynex (ZYXI) United States $0.142B 15.17
Chimerix (CMRX) United States $0.103B 0.00
Chembio Diagnostics (CEMI) United States $0.101B 0.00
Female Health (VERU) United States $0.098B 0.00
United-Guardian (UG) United States $0.088B 18.33
Conatus Pharmaceuticals (CNAT) United States $0.087B 0.00
InfuSystems Holdings (INFU) United States $0.087B 0.00
CAS Medical Systems (CASM) United States $0.071B 0.00
Trinity Biotech (TRIB) Ireland $0.069B 20.64
Oramed Pharmaceuticals (ORMP) United States $0.058B 0.00
Neurotrope (NTRP) United States $0.056B 0.00
Valeritas Holdings (VLRX) United States $0.038B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Senestech (SNES) United States $0.025B 0.00
Capricor Therapeutics (CAPR) United States $0.017B 0.00
Myomo (MYO) United States $0.016B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.015B 0.00
Akers Biosciences Inc (AKER) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.014B 0.00
NeuroMetrix (NURO) United States $0.008B 15.00